End-stage Heart Failure Clinical Trial
Official title:
Left Ventricular Assist Device (LVAD) Versus Guideline Recommended Medical Therapy in Ambulatory Advanced Heart Failure Patients (GDMT)
Heart failure is a severe disease affecting approximately 1-2% of the adult population in developed countries and around 26 million people worldwide. Up to 10% of these patients are in advanced stage heart failure, which is defined by a significant morbimortality and considerable medical expenses. Despite advances in its medical management, advanced (or end stage) heart failure is characterized by refractoriness to conventional therapies including guideline-directed pharmacological and non-surgical device treatments. These patients remain severely symptomatic (NYHA IV) and have objective signs of congestion or low cardiac output. Left ventricular assist devices (LVADs) have been used in patients with heart failure with reduced ejection fraction for almost 20 years either as an alternative or a bridge to heart transplantation. LVADs improve heart failure symptoms and survival at the cost of increased rates of infection, stroke and bleeding. Despite the lack of evidence, LVAD implantation in ambulatory patients is not rare, with INTERMACS profiles ≥4 patients representing 15.7% of the overall population implanted between 2012 and 2016. The aim of this study is to investigate the efficacy and safety of left ventricular assist devices compared to traditional HF medical treatment alone in a population of ambulatory advanced heart failure patients. Secondary objectives are to better identify subgroups of patients that would benefit the most from the implantation of an LVAD as well as to assess the optimal timing of intervention.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06063811 -
Ventricular Tachycardia Ablation in LVAD Patients
|
||
Withdrawn |
NCT04782245 -
Acute Reno-Cardiac Action of Dapagliflozin In Advanced Heart Failure Patients on Heart Transplant Waiting List
|
Phase 2 | |
Active, not recruiting |
NCT04351945 -
Endocrine Changes and Their Correction in Heart and Lung Transplant Recipients and Donors
|
||
Recruiting |
NCT03966313 -
Perioperative Modification of Hemostasis During Ventricular Assist Device Implantation
|
||
Recruiting |
NCT02592499 -
Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure
|
N/A | |
Active, not recruiting |
NCT00490321 -
VentrAssistTM LVAD for the Treatment of Advanced Heart Failure - Destination Therapy
|
Phase 3 | |
Active, not recruiting |
NCT00483197 -
VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Pivotal Trial
|
Phase 3 | |
Completed |
NCT04543747 -
Mechanical Circulatory Support Korea Post Market Surveillance Study (PMS)
|
||
Recruiting |
NCT04293575 -
Transcatheter Mitral Valve Repair as Bridge Therapy to Heart Transplantation
|
||
Recruiting |
NCT04641416 -
Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood Pumps
|
||
Completed |
NCT00490347 -
VentrAssistTM LVAD as a Bridge to Cardiac Transplantation - Feasibility Trial
|
Phase 2 | |
Suspended |
NCT04117295 -
Carmat TAH Early Feasibility Study
|
N/A | |
Completed |
NCT05353816 -
Corheart 6 Left Ventricular Assist System Prospective, Multicenter, Single-arm Clinical Evaluation Trial
|
N/A | |
Completed |
NCT04480151 -
ECLS Versus IMPELLA™ as Bridge to LVAD (ECI-BLAD)
|
||
Recruiting |
NCT04205760 -
Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device
|
Phase 3 | |
Recruiting |
NCT06345521 -
Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure
|
||
Completed |
NCT02248974 -
Development & Testing of a Decision Aid for LVAD Placement
|
N/A | |
Completed |
NCT06152562 -
Evaluation of Platelet Therapy Response in Left Ventricular Assist Device Patients
|
||
Completed |
NCT05928273 -
Corheart 6 LVAS LTFU
|
N/A | |
Recruiting |
NCT04951999 -
AssocIation of PULSatility and Occurrence of Complications Related to Mechanically Assisted Circulatory Support
|
N/A |